CellOrigin Biotech
PrivateLast Round
Early Funding
Sep 21, 2023
Total Funding Raised
$13.8M
Company Overview
CellOrigin Biotech is a biotechnology company that develops genetically engineered iPSC-derived immune cell therapies for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellOrigin Biotech Comparables
Compare CellOrigin Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 89% | |
| Neukio Biotherapeutics | 87% | |
| HebeCell | 82% | |
CellOrigin Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 21, 2023 | ||||
| Early Funding | Feb 16, 2022 | ||||
| Angel | Jul 16, 2021 |
CellOrigin Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Early Funding |
| Nest.Bio | Angel |
| Kunlun Capital | Angel |
| Shulan Health | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2021
Led by Kunlun Capital
CellOrigin Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellOrigin Biotech's valuation, stock price, and market status.